Cano Health, Inc.

CANOQ Healthcare Medical Care Facilities

Cano Health, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $3.1 billion, up 14.6% from fiscal 2022. Revenue growth for five consecutive years, operating cash flow growth for three.

0.24 0.00 0.00%
Market cap
$6.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
3/9
Altman Z
−2.84
Beneish M
−7.85
Dividend safety
n/a

Cano Health, Inc. (CANOQ) EV/Sales

Alert me on EV/Sales

As of 28 June 2024, Cano Health, Inc. (CANOQ) trades at a EV/Sales of 0.0×. Over the past ten years it has ranged from 0.0× (June 2024) to 118× (June 2021); the current reading is higher than 5% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2023 0.0× —
FY2022 0.5× (67.14%)
FY2021 1.4× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/Sales Change
Mar 2024 0.0× —
Dec 2023 0.0× —
Sep 2023 0.3× (24.61%)
Jun 2023 0.4× 5.05%
12 more quarters

Against its own ten years

Low 0.0× High 118×
Ten-year median 0.5×
Current reading's percentile 5

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on CANOQ